
Monday, May 12, 2025 3:52:19 PM
Recent ANIP News
- ANI Pharmaceuticals Announces Presentation of New Preclinical Data • GlobeNewswire Inc. • 06/12/2025 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 06/04/2025 08:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2025 11:10:42 AM
- ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/27/2025 08:30:00 PM
- ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares • GlobeNewswire Inc. • 05/22/2025 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2025 08:29:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2025 08:21:52 PM
- ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ • GlobeNewswire Inc. • 05/12/2025 10:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2025 12:50:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 10:57:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2025 10:55:20 AM
- ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance • GlobeNewswire Inc. • 05/09/2025 10:50:08 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/08/2025 01:15:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 01:14:26 PM
- ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model • GlobeNewswire Inc. • 05/05/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2025 08:17:11 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2025 08:42:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2025 08:40:20 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2025 08:38:27 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/10/2025 08:00:18 PM
- ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET • GlobeNewswire Inc. • 04/09/2025 10:50:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/31/2025 08:35:44 PM
- ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference • GlobeNewswire Inc. • 03/31/2025 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2025 08:47:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2025 08:44:49 PM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM
NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM
Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM